Mutational analysis and clinical investigations of medically diagnosed GSD 1a patients from Pakistan
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0288965 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Bushra Gul und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan. Hauptthemen laut MEDLINE: Glycogen Storage Disease Type I. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glycogen storage disease type I (GSD I) is a rare autosomal recessive inborn error of carbohydrate metabolism caused by the defects of glucose-6-phosphatase complex ( G6PC ). Disease causing variants in the G6PC gene, located on chromosome 17q21 result in glycogen storage disease type Ia (GSD Ia). Age of onset of GSD Ia ranges from 0.5 to 25 years with presenting features including hemorrhage, hepatic, physical and blood related abnormalities. The overall goal of proposed study was clinical and genetic characterization of GSD Ia cases from Pakistani population. This study included forty GSD Ia cases presenting with heterogeneous clinical profile including hypoglycemia, hepatomegaly, lactic acidosis i.e., pH less than 7.2, hyperuricemia, seizures, epistaxis, hypertriglyceridemia (more than180 mg/dl) and sometimes short stature. All coding exons and intron-exon boundaries of G6PC gene were screened to identify pathogenic variant in 20 patients based on availability of DNA samples and willingness to participate in molecular analysis. Pathogenic variant analysis was done using PCR-Sanger sequencing method and pathogenic effect predictions for identified variants were carried out using PROVEAN, MutationTaster, Polyphen 2, HOPE, Varsome, CADD, DANN, SIFT and HSF software. Overall, 21 variants were detected including 8 novel disease causing variants i.e., G6PC (NM_000151.4):c.71A>C (p.Gln24Pro), c.109G>C(p.Ala37Pro), c.133G>C(p.Val45Leu), c.49_50insT c.205G>A(p.Asp69Asn), c.244C>A(p.Gln82Lys) c.322A>C(p.Thr108Pro) and c.322A>C(p.Cys284Tyr) in the screened regions of G6PC gene. Out of 13 identified polymorphisms, 3 were identified in heterozygous condition while 10 were found in homozygous condition. This study revealed clinical presentation of GSD Ia cases from Pakistan and identification of novel disease-causing sequence variants in coding region and intron-exon boundaries of G6PC gene.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Zoology, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
- Department of Biosciences, University of Wah, Wah Cantt, Pakistan.
ORCID-Profile: Sabika Firasat
Zitieren
APA
Gul, B., Firasat, S., Shan, T., Tehreem, R., & Afshan, K. (2023). Mutational analysis and clinical investigations of medically diagnosed GSD 1a patients from Pakistan. PLOS ONE. https://doi.org/10.1371/journal.pone.0288965
Vancouver
Gul B, Firasat S, Shan T, Tehreem R, Afshan K. Mutational analysis and clinical investigations of medically diagnosed GSD 1a patients from Pakistan. PLOS ONE. 2023. doi:10.1371/journal.pone.0288965
BibTeX
@article{Gul2023,
author = {Gul, Bushra and Firasat, Sabika and Shan, Tayyaba and Tehreem, Raeesa and Afshan, Kiran},
title = {Mutational analysis and clinical investigations of medically diagnosed GSD 1a patients from Pakistan},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0288965}
}
EUVIMED